Release Date: March 23, 2012
National Institute on Deafness and Other Communication
This Notice announces that the National Institute on Deafness and Other Communication Disorders (NIDCD) is expiring three Funding Opportunity Announcements (FOAs) that encourage Clinical Trial grant applications. These three FOAs are being terminated effective immediately because NIDCD has converted its Clinical Trials program over to the use of Cooperative Agreement support mechanisms and published new FOAs for that purpose on March 16, 2012.
FOAs expired include:
PAR-08-205 NIDCD Phase III Definitive Clinical Trials in Communication Disorders (R01)
PAR-09-142 NIDCD Definitive Phase III Clinical Trial Planning Grant (R34)
PAR-11-290 NIDCD Phase I/II Preliminary Clinical Trials in Communication Disorders (R01)
New FOAs published (3-16-2012) include:
PAR-12-123 NIDCD Phase I/II/III Clinical Trials in Communication Disorders (U01)
PAR-12-124 NIDCD Planning Grant for Phase III Clinical Trials in Communication Disorders (U34)
Please direct all inquiries to:
Gordon B. Hughes, M.D.
Division of Scientific Programs
National Institute on Deafness and Other Communication Disorders
6120 Executive Blvd.
EPS-400C MSC 7180
Bethesda, MD 20892-7180
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
NIH . . . Turning Discovery Into Health
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.